Dindolyl Methane, or DIM as it is commonly referred to, is a well-known supplement for bodybuilders as well as other individuals interested in enhancing muscle growth. However there have been recent links to health hazards that DIM can trigger. DIM can cause liver damage if consumed in excessive amounts. Kidney damage can also be an issue, and could lead to kidney failure. Many bodybuilders and athletes are worried about the long-term health risks associated with DIM.
The majority of people take a diindolylmethane supplement to improve the production of testosterone. It is known that testosterone acts as an androgen. This means that it can trigger hormonal changes within the tissues. DIM has been demonstrated in studies to mimic the effects of testosterone, as well as other hormones. Since men produce more testosterone than women do Some manufacturers have added diindolylmethane into their products in order to increase their competitiveness in male circles. Men will react to products that mimic natural testosterone.
As a result, many companies advertise DIM as a cancer suppressor. It is true that diindolylmethane can decrease the growth of tumors in laboratory animals, however these animals were administered the drug, not orally. To achieve the same result in humans, diindolylmethane has to be consumed in large doses for a long period of time. The animals that were studied did not show symptoms of cancer for several years. However, they all developed liver disease after consuming excessive amounts of diindolylmethane. A medical practitioner can give you an understanding of how DIM is absorbed by the body.
According to the US National Institute of Environmental Health Safety and Security, the only way to prove that DIM is effective in treating breast cancer is to conduct an experiment wherein cells from healthy breast cancer cells are exposed to high doses of diindolylmethane over a prolonged period of time. Like any chemical there are pros and cons to using it. The advantages include the capability to mimic hormones. This allows you to create insulin that inhibits cancer cell growth. The downsides are that diindolylmethane is also able to produce an extremely harmful chemical known as DMSO. Know more about dim (diindolylmethane) now.
One of the most commonly used claims made for diindolylmethane as a treatment for various health issues is that it acts as a natural, anti-fungal, antibacterial, and anti-cancer agent. These claims were rejected by the National Institute of Health after an exhaustive review of supporting research. According to the Institute of Chemical Technology there was no evidence from any research that support this claim. In a thorough examination of the safety profile of the firestone the Institute of Chemical Safety concluded that the evidence provided by pharmaceutical companies on the human benefits of diindolylmethane was not substantiated.
In the May 2021 issue of the Journal of Toxicology and Environmental Health, van der Goes, et al. identified a variety of potential dangers that could be posed by diindolylmethane’s use such as allergic reactions to the skin, asthma attacks, dizziness, headaches, and respiratory issues. The daily dose recommended for this chemical, which is roughly one tenth of one teaspoon was 0.2 milligrams. It is unclear what the concentration will be when this chemical is mixed with other substances. This substance isn’t safe because it has not been thoroughly tested.
The abstract of the view indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the principle of inhibiting intracellular inhibition of pyruvate metabolite by flavenoids, and thereby stopping the accumulation of oxalates within renal tubule cells as well as adenine granulocyte cultures. However, the metabiplicate drug toxicology studies did not provide convincing evidence that consumption of this chemical causes an overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the company that makes firestone tincture is in process of conducting two major studies – one in Europe and one in the United States.
The abstract of the view also indicates that diindolylmethane’s use in the treatment of cancer is based on the principle of inhibiting intracellular inhibition via flavenoids of pyruvate metabolism , and thus stopping the accumulation of adenine and oxalates in the renal tubule cells. However, the drug metabiplicate studies failed to provide convincing evidence that the consumption of this chemical can cause an overdose. The Food and Drug Administration approved this substance as a prescription drug in June 1996. According to the FDA the company that makes firestone Tincture is currently completing two major trials in Europe and the United States. According to FDA, the FDA states that the manufacturer of firestone Tincture is currently conducting two major studies in Europe and one in the United States.